Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
Cigna Group (NYSE: CI) closed the day trading at $244.41 down -1.09% from the previous closing price of $247.1. In other words, the price has decreased by -$1.09 from its previous closing price. On the day, 5.14 million shares were traded. CI stock price reached its highest trading level at $248.525 during the session, while it also had its lowest trading level at $240.67.
Ratios:
For a better understanding of CI, let’s look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.81 whereas as Long-Term Debt/Eq ratio is at 0.74.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for this company, Goldman on October 14, 2025, initiated with a Buy rating and assigned the stock a target price of $370.
On February 06, 2025, Bernstein Downgraded its rating to Mkt Perform which previously was Outperform but kept the price unchanged to $323.
On June 26, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $400.Piper Sandler initiated its Overweight rating on June 26, 2024, with a $400 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 03 ’25 when Evanko Brian C sold 5,368 shares for $300.00 per share. The transaction valued at 1,610,400 led to the insider holds 51,182 shares of the business.
Evanko Brian C bought 5,368 shares of CI for $1,610,400 on Oct 03 ’25. On Aug 15 ’25, another insider, Jones Nicole S, who serves as the insider of the company, sold 28,526 shares for $300.00 each. As a result, the insider received 8,557,800 and left with 25,648 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CI now has a Market Capitalization of 65288224768 and an Enterprise Value of 92629221376. As of this moment, Cigna’s Price-to-Earnings (P/E) ratio for their current fiscal year is 10.78, and their Forward P/E ratio for the next fiscal year is 7.73. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.21. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.24 while its Price-to-Book (P/B) ratio in mrq is 1.56. Its current Enterprise Value per Revenue stands at 0.346 whereas that against EBITDA is 7.939.
Stock Price History:
The Beta on a monthly basis for CI is 0.45, which has changed by -0.21743727 over the last 52 weeks, in comparison to a change of 0.19736934 over the same period for the S&P500. Over the past 52 weeks, CI has reached a high of $350.00, while it has fallen to a 52-week low of $245.61. The 50-Day Moving Average of the stock is -17.76%, while the 200-Day Moving Average is calculated to be -20.28%.
Shares Statistics:
Over the past 3-months, CI traded about 1.74M shares per day on average, while over the past 10 days, CI traded about 2547950 shares per day. A total of 266.60M shares are outstanding, with a floating share count of 263.13M. Insiders hold about 1.50% of the company’s shares, while institutions hold 89.49% stake in the company. Shares short for CI as of 1760486400 were 3776937 with a Short Ratio of 2.17, compared to 1757894400 on 3261016. Therefore, it implies a Short% of Shares Outstanding of 3776937 and a Short% of Float of 1.87.
Dividends & Splits
CI’s forward annual dividend rate is 5.93, up from 5.93 a year ago. Against a Trailing Annual Dividend Yield of 0.02399838. The stock’s 5-year Average Dividend Yield is 1.45. . The current Payout Ratio is 46.19% for CI, which recently paid a dividend on 2025-09-04 with an ex-dividend date of 2025-12-04. Stock splits for the company last occurred on 2007-06-05 when the company split stock in a 3:1 ratio.
Earnings Estimates
A comprehensive evaluation of Cigna Group (CI) is underway, with the input of 20.0 analysts contributing to its current rating.The consensus estimate for the next quarter is $7.47, with high estimates of $8.22 and low estimates of $6.9.
Analysts are recommending an EPS of between $29.76 and $29.0 for the fiscal current year, implying an average EPS of $29.62. EPS for the following year is $31.47, with 23.0 analysts recommending between $34.0 and $30.04.
Revenue Estimates
9 analysts predict $68.87B in revenue for . The current quarter. It ranges from a high estimate of $74.72B to a low estimate of $65.32B. As of . The current estimate, Cigna Group’s year-ago sales were $65.68BFor the next quarter, 9 analysts are estimating revenue of $66.92B. There is a high estimate of $71.2B for the next quarter, whereas the lowest estimate is $64.28B.
A total of 14 analysts have provided revenue estimates for CI’s current fiscal year. The highest revenue estimate was $277.15B, while the lowest revenue estimate was $253.3B, resulting in an average revenue estimate of $267.61B. In the same quarter a year ago, actual revenue was $247.1BBased on 13 analysts’ estimates, the company’s revenue will be $279.85B in the next fiscal year. The high estimate is $306.37B and the low estimate is $263.33B.
